Related Experiment Video
Updated: Aug 5, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
The Diabetes Control and Complications Trial (DCCT)
1Guy's Hospital, London.
Health Trends
|December 9, 1993
Summary
Intensified blood sugar control in diabetes significantly reduces the risk of major complications like retinopathy, nephropathy, and neuropathy. However, this approach also increases the risk of severe hypoglycemia, with no impact on quality of life.
Area of Science:
- Endocrinology
- Clinical Medicine
- Diabetology
Background:
- The Diabetes Control and Complications Trial (DCCT) addressed the long-standing debate on diabetes management.
- Understanding the impact of glycemic control on diabetes complications is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of intensified diabetes control versus conventional control.
- To assess the impact on major diabetes complications, including retinopathy, nephropathy, and neuropathy.
Main Methods:
- Randomized controlled trial involving 1,441 patients with insulin-dependent diabetes.
- Comparison of intensified versus conventional glycemic control strategies.
- Primary outcome: appearance or advancement of clinically significant retinopathy.
Main Results:
- Intensified control reduced retinopathy risk by 50% or more in both primary prevention and secondary intervention groups.
- Significant reductions in nephropathy and neuropathy risks were observed with intensified control.
- A threefold increase in the risk of severe hypoglycemic episodes was associated with intensified control.
Conclusions:
- Intensified glycemic control is effective in reducing major diabetes complications.
- The benefits of reduced microvascular complications must be weighed against the increased risk of severe hypoglycemia.
- No significant differences were found in quality of life or neurocognitive assessments between the groups.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...